Atossa Therapeutics, Inc. (ATOS) Earnings Per Share (EPS)
Atossa Therapeutics, Inc. (ATOS) earnings per share history, EPS estimates, and growth trends. Track EPS in Excel with MarketXLS.
EPS (Earnings Per Share) Data
| Period | Diluted EPS (USD) |
|---|---|
| 2016-12-31 | N/A |
| 2017-12-31 | N/A |
| 2018-12-31 | N/A |
| 2019-12-31 | N/A |
| 2020-12-31 | -$29.55 |
| 2021-12-31 | -$2.70 |
| 2022-12-31 | -$3.15 |
| 2023-12-31 | -$3.60 |
| 2024-12-31 | -$3.00 |
| 2025-12-31 | -$4.04 |
How ATOS compares with sector peers
| Symbol | Company | Diluted EPS (latest fiscal year) |
|---|---|---|
| REPL | Replimune Group Inc. | -$3.38 |
| AXSM | Axsome Therapeutics Inc. | -$3.68 |
| VNDA | Vanda Pharmaceuticals Inc. | -$3.74 |
| CELC | Celcuity Inc. | -$3.79 |
| NTLA | Intellia Therapeutics Inc. | -$3.81 |
These are five companies in the same sector as ATOS with a comparable annual diluted earnings per share. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Atossa Therapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =EarningsPerShare("ATOS")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | ATOS | $2.37 | +0.42% | 0.07M |
| 3 | ||||
| 4 | ||||
| 5 |